Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Ability to lose weight during different obesity treatments shows substantial variability between individuals and is likely under genetic control; however, the underlying predictive variants and weight loss genes remain unknown. Here we profiled longitudinal, single cell level adipose transcriptomes of individuals undergoing bariatric surgery to elucidate genes and their regulatory variants contributing to interindividual variability in weight loss outcomes. We identified wide-spread cellular and subcellular transcriptional changes to weight loss with most profound responses in adipocyte subtypes. By clustering the weight loss genes based on their cell-type level co-expression profiles, we uncovered functionally distinct subsets of genes reflecting altered adipocyte expression of central adipocyte function enriched genes. Next, we discovered that body mass index (BMI) polygenic risk score (PRS) built using the regulatory variants in these 45 adipocyte weight loss genes significantly predict the magnitude of the achieved weight loss and are strongly enriched for variance explained in the change of BMI. Taken together, this longitudinal single nucleus adipose data establishes gene signatures for weight loss and discovers genetic regulators underlying the interindividual variability of weight loss.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12338903 | PMC |
| http://dx.doi.org/10.1101/2025.07.11.25331390 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Exploratory Assessment of Preoperative GLP-1 Receptor Agonists Before Sleeve Gastrectomy: A Retrospective Matched Analysis.
Obes Surg
September 2025
Clinique Mutualiste de Pessac, Pessac, France.
Background: Preoperative treatment with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) before bariatric surgery has not been studied. Therefore, we investigated the impact of neoadjuvant treatment with GLP-1 RAs on weight loss and postoperative outcomes in patients who underwent sleeve gastrectomy for severe obesity.
Method: A retrospective single-center study was conducted between January 2022 and December 2023.
Using obesity management medications within the first year after laparoscopic sleeve gastrectomy may enhance weight-loss outcomes.
Obes Surg
September 2025
E-Da Hospital, Kaohsiung City, Taiwan.
Background: We retrospectively evaluated the efficacy of using additional obesity management medications (OMMs) within the first year after undergoing laparoscopic sleeve gastrectomy (LSG).
Methods: We retrospectively analyzed 246 patients who underwent primary LSG in our institution and were followed up for at least 12 months. We collected body weights preoperatively and at three, six, 12, and 24 months postoperatively, along with body composition and laboratory results preoperatively and at 12 months.
Quantifying Malabsorption After Roux-en-Y Gastric Bypass and Sleeve Gastrectomy Using Near Infrared Spectroscopy.
Obes Surg
September 2025
Department of Experimental Vascular Medicine, Amsterdam University Medical Centers, Amsterdam, Netherlands.
Background: Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) are common bariatric procedures that lead to substantial and sustained weight loss. Although both procedures induce hormonal and physiological effects, RYGB includes both a restrictive and malabsorptive component due to anatomical rerouting, whereas SG is considered primarily restrictive. This study aimed to quantify differences in energy and fat absorption between both procedures using near-infrared spectroscopy (NIRS).
View Article and Find Full Text PDFBariatric surgery is an effective treatment for morbid obesity, but patient outcomes differ greatly because of a variety of phenotypes, comorbidities, and postoperative adherence. In bariatric care, artificial intelligence (AI) and machine learning (ML) are becoming revolutionary tools because traditional predictive models based on BMI and demographic variables are unable to account for these complexities. To put it simply, AI is a branch of computer science that enables machines to perform tasks that typically require human intelligence.
View Article and Find Full Text PDFMolecular subtypes of human skeletal muscle in cancer cachexia.
Nature
September 2025
Department of Laboratory Medicine and Pathology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.
Cancer-associated muscle wasting is associated with poor clinical outcomes, but its underlying biology is largely uncharted in humans. Unbiased analysis of the RNAome (coding and non-coding RNAs) with unsupervised clustering using integrative non-negative matrix factorization provides a means of identifying distinct molecular subtypes and was applied here to muscle of patients with colorectal or pancreatic cancer. Rectus abdominis biopsies from 84 patients were profiled using high-throughput next-generation sequencing.
View Article and Find Full Text PDF